Motrin Pain Reliever Recalled for Distribution Center Sanitation Violations
Gold Star Distribution Inc. recalls all lots of Motrin 2's pain reliever (50-count dispensers) distributed nationwide due to CGMP deviations including insanitary conditions and rodent exposure at their distribution center.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall. The source describes facility-level CGMP deviations and insanitary conditions including rodent exposure without mentioning any reported illnesses or injuries, indicating a risk-of-harm scenario without confirmed adverse effects.
Plain-English summary
Gold Star Distribution Inc. is recalling MOTRIN 2's DISP.- 50CT, an over-the-counter pain reliever, distributed nationwide. The recall includes all lots within expiration date that were distributed by the company.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations identified at the distributor's distribution center. Insanitary conditions, including rodent exposure and activity, were documented in the facility.
The product was distributed nationwide. The recall affects all lots of MOTRIN 2's DISP.- 50CT distributed by Gold Star Distribution that remain within their expiration dates.
Consumers with questions about this recall are advised to consult their healthcare provider regarding their use of the product.
The recalled product
- Product
- MOTRIN 2'S DISP.- 50CT
- Manufacturer
- GOLD STAR DISTRIBUTION INC
- Category
- Drug — Pain Reliever
- Hazard
- rodent-contamination
- cgmp-violation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry distributed by Gold Star Distribution.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27